Breaking the Silence: Challenges and Opportunities in Pediatric Drug Development

Faegre Drinker Consulting principal Timothy Franson co-authored a study, “Breaking the Silence: Challenges and Opportunities in Pediatric Drug Development,” for Pediatric Research, that provides insights on current and potential trends in pediatric pharmaceutical care.

In the study, Franson discusses how current pediatric care options are limited and often lack concrete evidence from well-controlled trials, and advocates for incorporating a global regulatory framework to help overcome obstacles in pharmacy care for children.

The full study is available to subscribers.